InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Tsai John. Insider active across 1 company, notably Blueprint Medicines Corp. Aggregated, 5 filings have been published. History available since 6 January 2023. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Tsai John is a declarant linked to Blueprint Medicines Corp, where he is a Director. His record includes 5 filings, and the most recent sampled filings cover the period from 2023-01-09 to 2025-07-21; the dominant transaction nature is Attribution. In this sample, both buy and sell amounts are 0 EUR.